Treatment of skeletally mature ovariectomized rhesus monkeys with PTH(1-84) for 16 months increases bone formation and density and improves trabecular architecture and biomechanical properties at the lumbar spine

被引：40

作者：

Fox, John

Miller, Michael A.

Newman, Michael K.

Turner, Charles H.

Recker, Robert R.

Smith, Susan Y.

机构：

[1] NPS Pharmaceut Inc, Salt Lake City, UT 84108 USA

[2] Indiana Univ, Dept Orthopaed Surg, Indianapolis, IN USA

[3] Creighton Univ, Osteoporosis Res Ctr, Omaha, NE 68178 USA

[4] Charles River Labs, Preclin Serv, Montreal, PQ, Canada

来源：

JOURNAL OF BONE AND MINERAL RESEARCH | 2007年 / 22卷 / 02期

关键词：

ovariectomized primate; PTH; bone turnover markers; bone densitometry; bone histomorphometry; bone strength;

D O I：

10.1359/JBMR.061101

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Histomorphometric studies of treatments for osteoporosis in humans are restricted to iliac crest biopsies. We studied the effects of PTH(1-84) treatment at the lumbar spine of skeletally mature ovariectomized rhesus monkeys. PTH increased bone turnover, rapidly normalized BMD, and increased vertebral compressive strength. PTH increased trabecular bone volume primarily by increasing trabecular number by markedly increasing intratrabecular tunneling.

引用

收藏

页码：260 / 273

页数：14

相关论文

共 36 条

[1] Zoledronate prevents the development of absolute osteopenia following ovariectomy in adult rhesus monkeys [J].

Binkley, N ;

Kimmel, D ;

Bruner, J ;

Haffa, A ;

Davidowitz, B ;

Meng, C ;

Schaffer, V ;

Green, J .

JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (11) :1775-1782

[2] In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography [J].

Boutroy, S ;

Bouxsein, ML ;

Munoz, F ;

Delmas, PD .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (12) :6508-6515

[3]

Boyce RW, 1996, J BONE MINER RES, V11, P600

[4] Daily treatment with human recombinant parathyroid hormone-(1-34), LY333334, for 1 year increases bone mass in ovariectomized monkeys [J].

Brommage, R ;

Hotchkiss, CE ;

Lees, CJ ;

Stancill, MW ;

Hock, JM ;

Jerome, CP .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) :3757-3763

[5] Intermittently administered human parathyroid hormone(1-34) treatment increases intracortical bone turnover and porosity without reducing bone strength in the humerus of ovariectomized cynomolgus monkeys [J].

Burr, DB ;

Hirano, T ;

Turner, CH ;

Hotchkiss, C ;

Brommage, R ;

Hock, JM .

JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (01) :157-165

[6]

Dempster DW, 2005, J BONE MINER RES, V20, pS98

[7] Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis:: A paired biopsy study [J].

Dempster, DW ;

Cosman, F ;

Kurland, ES ;

Zhou, H ;

Nieves, J ;

Woelfert, L ;

Shane, E ;

Plavetic, K ;

Müller, R ;

Bilezikian, J ;

Lindsay, R .

JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (10) :1846-1853

[8] Receptors for the carboxyl-terminal region of PTH(1-84) are highly expressed in osteocytic cells [J].

Divieti, P ;

Inomata, N ;

Chapin, K ;

Singh, R ;

Jüppner, H ;

Bringhurst, FR .

ENDOCRINOLOGY, 2001, 142 (02) :916-925

[9] Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy [J].

Dobnig, H ;

Sipos, A ;

Jiang, YB ;

Fahrleitner-Pammer, A ;

Ste-Marie, LG ;

Gallagher, JC ;

Pavo, I ;

Wang, JY ;

Eriksen, EF .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (07) :3970-3977

[10]

Fox J., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P356

← 1 2 3 4 →